Thin-Shelled PEGylated Perfluorooctyl Bromide Nanocapsules for Tumor-Targeted Ultrasound Contrast Agent

Figure 9

Echogenicity evaluation in the blood vessels. NCm100 enhanced inferior vena cava (yellow arrow) and disappeared within 22s (a) shortly before injection, (b) shortly after injection, and (c) 20s after injection. L, liver.